MedPath

Human Epididymis Protein 4 in Normal Menstruating Women

Conditions
Healthy Premenopausal Women
Interventions
Other: blood draws
Registration Number
NCT01337999
Lead Sponsor
Women and Infants Hospital of Rhode Island
Brief Summary

The purpose of this study is to determine if Human Epididymis Protein 4 (HE-4) levels vary during the menstrual cycles in ovulatory women. HE-4 is a sensitive serological marker that is elevated in certain ovarian and endometrial cancers and can aid in the diagnosis of these malignant conditions. In order to optimize the utility of HE4 as a tumor marker in premenopausal women, its expression in the normal menstrual cycle needs to be characterized. We hypothesize that HE-4 levels do not vary in the menstrual cycle.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • women age 18-45 years old
  • regular menstrual cycles (every 25-35 days)
  • normal BMI (19-25)
  • no hormonal contraception in the two menstrual cycles prior to enrollment
Exclusion Criteria
  • pregnancy
  • pelvic mass

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
HE-4 levels, healthy premenopausal womenblood draws-
Primary Outcome Measures
NameTimeMethod
HE-4 level5 times during menstrual cycle
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Women & Infants Hospital of Rhode Island, Division of Reproductive Endocrinology & Infertility

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath